Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay

Clin Endocrinol (Oxf). 2025 Jan;102(1):62-66. doi: 10.1111/cen.15142. Epub 2024 Oct 1.

Authors

Hady Gad¹, Su Ann Tee², Christopher Boot³, Andy James¹, Salman Razvi², Yaasir Mamoojee¹; RVI Endocrine Group

Collaborators

RVI Endocrine Group:
Anna Mitchell, Catherine Napier, Earn Gan, Petros Perros, Richard Quinton, Simon Pearce

Affiliations

¹ Department of Endocrinology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
² Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, UK.
³ Department of Blood Sciences, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.

PMID: 39351846
DOI: 10.1111/cen.15142

No abstract available

Keywords: hyperprolactinaemia; prolactin; prolactinoma.

Publication types

Letter